The market is dominated by domestic suppliers, as imports account for 45.9% of total market size in 2023. B2B drives market demand, with B2B spending representing 44.3% of total demand in 2023. France has the second largest market size for pharmaceuticals regionally, with demand reaching USD94.4 billion in 2023. Sanofi SA AG is the largest company in France, generating 33.5% of the industry’s total production value in 2023. The industry is fragmented, with the top five companies generating 46.5% of total production value in 2023. The total number of companies decreases in 2023, to 1,002 units. The costs of the industry increase by 11.1% in 2023, largely driven by rising B2B costs. The industry’s profitability increases and stands at 3.5% of production value in 2023, the 20th highest regionally. The industry’s exports share decreases in 2023 to 45.0% of total production output. With production value of USD65.1 billion, France accounts for 9.9% of the Western Europe total in 2023.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF.
This Euromonitor industrial report provides unique information on Pharmaceuticals in France: ISIC 2423. With this industrial report, you’ll be able to explore the industry from its sources of supply to its buyers. The Pharmaceuticals in France: ISIC 2423 report includes: Industry datagraphics including production data, exports, imports, cost structure, and profitability
Pharmaceuticals and Medical Equipment is an aggregation of Pharmaceuticals, Medical and Surgical Equipment.
See all of our definitionsIf you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!